BALKAN MEDICAL JOURNAL, cilt.32, sa.4, ss.388-396, 2015 (SCI İndekslerine Giren Dergi)
Background: Gastrointestinal stromal tumors (GIST) have KIT or platelet-derived growth factor receptor a (PDGFR alpha) mutations affecting receptor tyrosine kinase activity and do not benefit from classic treatment regimens.